Farmácia Popular Program: pharmaceutical market analysis of antihypertensive acting on the renin-angiotensin system medicines

Detalhes bibliográficos
Autor(a) principal: Silva,Rondineli Mendes da
Data de Publicação: 2017
Outros Autores: Chaves,Gabriela Costa, Chaves,Luisa Arueira, Campos,Mônica Rodrigues, Luiza,Vera Lucia, Bertoldi,Andréa Dâmaso, Ross-Degnan,Dennis, Emmerick,Isabel Cristina Martins
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Ciência & Saúde Coletiva (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-81232017002802501
Resumo: Abstract This paper aims to analyse changes in the retail pharmaceutical market following policy changes in the Farmácia Popular Program (FP), a medicines subsidy program in Brazil. The retrospective longitudinal analyses focus on therapeutic class of agents acting on the renin-angiotensin system. Data obtained from QuintilesIMS (formerly IMS Health) included private retail pharmacy sales volume (pharmaceutical units) and sales values from 2002 to 2013. Analyses evaluated changes in market share following key FP policy changes. The therapeutic class was selected due to its relevance to hypertension treatment. Market share was analysed by therapeutic sub-classes and by individual company. Losartan as a single product accounted for the highest market share among angiotensin II antagonists. National companies had higher sales volume during the study period, while multinational companies had higher sales value. Changes in pharmaceutical market share coincided with the inclusion of specific products in the list of medicines covered by FP and with increases in or exemption from patient copayment.
id ABRASCO-2_510a53aca53850fe79d77ccd25330d4a
oai_identifier_str oai:scielo:S1413-81232017002802501
network_acronym_str ABRASCO-2
network_name_str Ciência & Saúde Coletiva (Online)
repository_id_str
spelling Farmácia Popular Program: pharmaceutical market analysis of antihypertensive acting on the renin-angiotensin system medicinesPharmaceutical tradeAntihypertensive agentsInterrupted time series analysisPharmaceutical servicesGovernment programsAbstract This paper aims to analyse changes in the retail pharmaceutical market following policy changes in the Farmácia Popular Program (FP), a medicines subsidy program in Brazil. The retrospective longitudinal analyses focus on therapeutic class of agents acting on the renin-angiotensin system. Data obtained from QuintilesIMS (formerly IMS Health) included private retail pharmacy sales volume (pharmaceutical units) and sales values from 2002 to 2013. Analyses evaluated changes in market share following key FP policy changes. The therapeutic class was selected due to its relevance to hypertension treatment. Market share was analysed by therapeutic sub-classes and by individual company. Losartan as a single product accounted for the highest market share among angiotensin II antagonists. National companies had higher sales volume during the study period, while multinational companies had higher sales value. Changes in pharmaceutical market share coincided with the inclusion of specific products in the list of medicines covered by FP and with increases in or exemption from patient copayment.ABRASCO - Associação Brasileira de Saúde Coletiva2017-08-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-81232017002802501Ciência & Saúde Coletiva v.22 n.8 2017reponame:Ciência & Saúde Coletiva (Online)instname:Associação Brasileira de Saúde Coletiva (ABRASCO)instacron:ABRASCO10.1590/1413-81232017228.01442017info:eu-repo/semantics/openAccessSilva,Rondineli Mendes daChaves,Gabriela CostaChaves,Luisa ArueiraCampos,Mônica RodriguesLuiza,Vera LuciaBertoldi,Andréa DâmasoRoss-Degnan,DennisEmmerick,Isabel Cristina Martinseng2017-08-02T00:00:00Zoai:scielo:S1413-81232017002802501Revistahttp://www.cienciaesaudecoletiva.com.brhttps://old.scielo.br/oai/scielo-oai.php||cienciasaudecoletiva@fiocruz.br1678-45611413-8123opendoar:2017-08-02T00:00Ciência & Saúde Coletiva (Online) - Associação Brasileira de Saúde Coletiva (ABRASCO)false
dc.title.none.fl_str_mv Farmácia Popular Program: pharmaceutical market analysis of antihypertensive acting on the renin-angiotensin system medicines
title Farmácia Popular Program: pharmaceutical market analysis of antihypertensive acting on the renin-angiotensin system medicines
spellingShingle Farmácia Popular Program: pharmaceutical market analysis of antihypertensive acting on the renin-angiotensin system medicines
Silva,Rondineli Mendes da
Pharmaceutical trade
Antihypertensive agents
Interrupted time series analysis
Pharmaceutical services
Government programs
title_short Farmácia Popular Program: pharmaceutical market analysis of antihypertensive acting on the renin-angiotensin system medicines
title_full Farmácia Popular Program: pharmaceutical market analysis of antihypertensive acting on the renin-angiotensin system medicines
title_fullStr Farmácia Popular Program: pharmaceutical market analysis of antihypertensive acting on the renin-angiotensin system medicines
title_full_unstemmed Farmácia Popular Program: pharmaceutical market analysis of antihypertensive acting on the renin-angiotensin system medicines
title_sort Farmácia Popular Program: pharmaceutical market analysis of antihypertensive acting on the renin-angiotensin system medicines
author Silva,Rondineli Mendes da
author_facet Silva,Rondineli Mendes da
Chaves,Gabriela Costa
Chaves,Luisa Arueira
Campos,Mônica Rodrigues
Luiza,Vera Lucia
Bertoldi,Andréa Dâmaso
Ross-Degnan,Dennis
Emmerick,Isabel Cristina Martins
author_role author
author2 Chaves,Gabriela Costa
Chaves,Luisa Arueira
Campos,Mônica Rodrigues
Luiza,Vera Lucia
Bertoldi,Andréa Dâmaso
Ross-Degnan,Dennis
Emmerick,Isabel Cristina Martins
author2_role author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Silva,Rondineli Mendes da
Chaves,Gabriela Costa
Chaves,Luisa Arueira
Campos,Mônica Rodrigues
Luiza,Vera Lucia
Bertoldi,Andréa Dâmaso
Ross-Degnan,Dennis
Emmerick,Isabel Cristina Martins
dc.subject.por.fl_str_mv Pharmaceutical trade
Antihypertensive agents
Interrupted time series analysis
Pharmaceutical services
Government programs
topic Pharmaceutical trade
Antihypertensive agents
Interrupted time series analysis
Pharmaceutical services
Government programs
description Abstract This paper aims to analyse changes in the retail pharmaceutical market following policy changes in the Farmácia Popular Program (FP), a medicines subsidy program in Brazil. The retrospective longitudinal analyses focus on therapeutic class of agents acting on the renin-angiotensin system. Data obtained from QuintilesIMS (formerly IMS Health) included private retail pharmacy sales volume (pharmaceutical units) and sales values from 2002 to 2013. Analyses evaluated changes in market share following key FP policy changes. The therapeutic class was selected due to its relevance to hypertension treatment. Market share was analysed by therapeutic sub-classes and by individual company. Losartan as a single product accounted for the highest market share among angiotensin II antagonists. National companies had higher sales volume during the study period, while multinational companies had higher sales value. Changes in pharmaceutical market share coincided with the inclusion of specific products in the list of medicines covered by FP and with increases in or exemption from patient copayment.
publishDate 2017
dc.date.none.fl_str_mv 2017-08-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-81232017002802501
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-81232017002802501
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/1413-81232017228.01442017
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv ABRASCO - Associação Brasileira de Saúde Coletiva
publisher.none.fl_str_mv ABRASCO - Associação Brasileira de Saúde Coletiva
dc.source.none.fl_str_mv Ciência & Saúde Coletiva v.22 n.8 2017
reponame:Ciência & Saúde Coletiva (Online)
instname:Associação Brasileira de Saúde Coletiva (ABRASCO)
instacron:ABRASCO
instname_str Associação Brasileira de Saúde Coletiva (ABRASCO)
instacron_str ABRASCO
institution ABRASCO
reponame_str Ciência & Saúde Coletiva (Online)
collection Ciência & Saúde Coletiva (Online)
repository.name.fl_str_mv Ciência & Saúde Coletiva (Online) - Associação Brasileira de Saúde Coletiva (ABRASCO)
repository.mail.fl_str_mv ||cienciasaudecoletiva@fiocruz.br
_version_ 1754213040630267904